A component of Mycobacterium bovis BCG referred to as BCG-a was isolated through the combined use of monoclonal antibody directed to BCG and affinity chromatography. Analysis of BCG-a by sodium dodecyl sulfate-polyacrylamide gel electrophoresis revealed a single prominent band with a molecular weight of ca. 10,000. Structural characterization of BCG-a consisting of amino acid composition and amino-terminal sequence determination was carried out. The intact BCG-a antigen was bound by neither the lectin from common lentils nor concanavalin A, implying that BCG-a does not carry any asparagine-linked oligosaccharides. Immunoprecipitation of '251-labeled BCG-a with polyclonal and monoclonal antibodies directed against BCG resulted in bands having the same mobility on sodium dodecyl sulfate-polyacrvlamide gel electrophoresis as did free '251-BCG-a. In radioimmunoassays 12I-BCG-a was bound by the monoclonal antibody and by polyclonal antibodies from rabbits that had been immunized to BCG and to Mycobacterium tuberculosis H37Rv. Antibodies to nontuberculous and to nonacid-fast bacteria bound BCG-a poorly or not at all. The binding of '25I-BCG-a by the monoclonal antibody was readily inhibited by extracts of BCG and H37Rv, but it was not as readily inhibited by extracts of nontuberculous mycobacteria and was not at all inhibited by extracts of nonacid-fast bacteria. Considerable inhibition was similarly observed by surface antigens of nonviable, intact BCG organisms. Delayed cutaneous hypersensitivity reactions to small concentrations of BCG-a were elicited in guinea pigs that had been immunized with BCG or H37Rv antigens, but such reactions were not elicited in unimmunized animals.
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Many constituents of the tubercle bacillus have been isolated and studied in a variety of ways. Intact cells and culture filtrates have been subjected to chemical fractionation, enzyme digestion, electrophoresis. gel filtration, and chromatography (6. 7, 9, 11. 13. 14. 28, 38) . As a result. many fractions have been isolated and partially defined with respect to their physical structure and biological properties. Some components were found that would react with circulating antibodies or elicit tuberculin-type skin sensitivity or both (2. 8, 29) . However, for reasons of sensitivity or specificity. none of these materials has been entirely satisfactory for study of the immune response to mycobacteria.
Monoclonal antibody techniques have recently been used to develop antibodies that react with some microbial antigens. They have been useful for the identification and characterization of such antigens (5, 6. 15. 16, 18. 21, 35-37, 39) . In this laboratory, hybridomas producing monoclonal antibodies to mycobacteria, including Mvcobacteri-iirn hovis BCG, have been prepared. Antibodies produced by one of the hybridomas and directed against BCG, have been studied in detail and are described in this report with respect to their capacity to detect antigens expressed by BCG. The monoclonal antibodies were conjugated to cyanogen bromide-activated Sepharose, and a soluble extract of BCG was passed through this immunoadsorbent. A component that bound to the antibodies was isolated and partially characterized.
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MATERIALS AND METHODS
Bacteria. The following bacteria obtained from the culture collection of this institution were grown as previously described (32, 33) P3X63Ag8653 myeloma cells (P3 cells), and fused with 40% polyethylene glycol 6000 as previously described (10, 13, 22, 23) . The fused cells were transferred to 96-well microculture plates at 106 cells per well. Each well had been seeded 24 h earlier with 5 x 103 peritoneal exudate cells obtained from normal unstimulated mice. The fused cell populations were cultured for 2 weeks in HAT medium (RPMI 1640 with 20% fetal bovine serum containing hypoxanthine, aminopterin, and thymidine). The growing hybrids were then cultured for another 7 days in medium containing hypoxanthine and thymidine. Supernatants from wells containing growing hybrids were tested in a solid-phase assay as described below. A hybridoma culture was selected that would bind to BCG-S but not to E. coli-S, L. monocytogenes-S, or Pseudomonas sp.-S antigens. The culture was expanded and cloned two times by limiting dilution. Hybridoma cells selected this way were also injected intraperitoneally into a group of normal BALB/c mice which had been primed intraperitoneally with 0.5 ml of pristane (2,6,10,14-tetramethylpentadecane) (Sigma Chemical Co., St. Louis, Mo.) 7 days earlier. Immunoglobulin G (IgG) was isolated from ascites by protein ASepharose affinity chromatography (Pharmacia Fine Chemicals, Piscataway, N.J.) as previously described (13) . Monoclonal antibodies derived from the ascites fluid are referred to as SA-12.
Preparation of BCG-a. Immunoadsorbents (IAD) were prepared by coupling SA-12 to cyanogen bromide-activated Sepharose 4B (Pharmacia Fine Chemicals) (11, 26) , and the washed IAD was transferred to a glass column. An IAD contained 50 mg of SA-12 in a 50-ml total volume. Phosphate-buffered saline (PBS), pH 7.0, was passed through the column, and ca. 35 mg of BCG-S was then passed through. Unbound substances were collected, and the column was washed with PBS until no protein was detected with a spectrophotometer set at 280 nm. Bound substances were then eluted with PBS, pH 3.5, and pooled according to optical density. The eluted material was designated BCG-a and was estimated to consist of less than 3% of the protein in the starting material. BCG-a was neutralized, dialyzed in a 1:10 dilution of PBS (pH 7.2), and concentrated by lyophilization. In some experiments BCG-a was passed through the IAD a second time. In binding and sodium dodecyl sulfatepolyacrylamide gel electrophoresis (SDS-PAGE) experiments, there were no significant differences in properties of BCG-a before or after a second IAD passage.
Radioiodination. BCG-a and staphylococcal protein-A (Pharmacia Fine Chemicals) were labeled with 125I by the chloramine-T method as previously described (34) . Labeled proteins are referred to as 125I-BCG-a and 125I-staphylococcal protein-A. Trichloroacetic acid precipitability of labeled antigens was usually 80 to 95%. Protein determinations. Protein was determined by the method of Lowry et al. (25) . When IgG preparations were tested, a rabbit IgG standard was used. When bacterial extracts were tested, the standard was a BCG extract whose protein concentration had been determined by a microKjeldahl method. Although extracts were measured only for their protein content, it is believed that proteins constituted only a portion of the components present.
Amino acid composition analysis of BCG-a. A 600-p.g sample of BCG-a was hydrolyzed with 6 N HCl at 110°C.
HCl was evaporated with a stream of N, and the hydrolysate was applied to a high-pressure liquid chromatography column of Dionex DC-4A resin (0.3 by 25 cm) and eluted with Dionex Hi-pH sodium buffer at a flow rate of 12 ml/h as previously described (4) . Amino acids were visualized with ninhydrin, and detectable amino acids were expressed as nanomoles per sample.
Amino-terminal sequence analysis. Two separate 250-p.g samples of affinity-purified BCG-a were subjected to Nterminal sequence determination with an Applied Biosystems model 470A gas-phase sequencer (17) . The phenylthiohydantoin amino acids produced by the sequencer were analyzed with a Waters high-pressure liquid chromatography system with a Novapak C 8 reverse-phase column. The mobile phase used to elute the phenylhydantoin-amino acids consisted of a gradient constructed from an A buffer of 83.3% 27.5 mM sodium acetate (pH 5.0 with acetic acid) and 16 (19) .
(ii) Precipitation of soluble antigen-antibody complexes by protein A-bearing Staphylococcus aureus. The capacities of antisera to bind BCG-a were tested by combining 0.1 ml of serial dilutions of antisera or monoclonal antibody with 0.1 ml of radiolabeled BCG-a. Dilutions of antisera and monoclonal antibody were made in normal rabbit serum previously diluted 1:5 in borate buffer, pH 8.4 (30) . Radiolabeled antigen-antibody complexes were then precipitated with protein A-bearing S. aureus (IgGsorb; Enzyme Center Inc., Boston, Mass.) (3) . Results are expressed as either counts per minute in the resulting precipitates or a percentage of the trichloroacetic acid-precipitable counts added that were detected in the precipitates. Details of this procedure and the calculations to correct for the small amount of binding of BCG-a by normal rabbit serum have been described previously (3, 30) . In inhibition experiments, 0.1 ml of antibody preparations were preincubated overnight with 0.1 ml of borate buffer, unlabeled BCG-a, bacterial extracts, or sus- pensions of unfractionated, heat-killed bacteria. ' -'I-BCG-a (0.1 ml) was then added, and binding capacities of sera were determined 24 h later. The protein concentration of 1-5[ BCG-a used for each test was ca. 0.03 kg of protein per 0.1 ml. Details of inhibition procedures have been described previously (29, 33) .
Immuno5precipitation and SDS-PAGE. Immunoprecipitation of -I-BCG-a by and by antibodies directed against various bacteria was performed as described previously (20 15 .000 cpm/0.1 ml), immunoprecipitated 25I-BCG-a, and unlabeled BCG-a was then carried out. Gels were stained with Coomassie brilliant blue (Bio-Rad Laboratories, Richmond, Calif.), heat-dried, exposed to X-Omat film (Eastman Kodak Co.. Rochester. N.Y.), and examined by radioautography.
The molecular weight of BCG-a was estimated by comparing its migration distance to that of selected molecularweight markers. Gels containing unlabeled antigens were stained before drying with a silver stain (Bio-Rad Laboratories) (27) . RESULTS Characteristics of BCG-a. BCG-a migrated as a single band after SDS-PAGE in a 12% gel (Fig. 1, lanes b and c) . Its molecular weight was estimated to be ca. 10,000. BCG-S (Fig. 1. lane a) contained multiple bands scattered throughout the gel as well as a prominent band in the 10,000-molecular-weight area that appeared to be the equivalent of BCG-a.
Radiolabeled BCG-a was combined with the anti-BCG monoclonal antibody, SA-12, and with polyclonal antisera to a variety of bacteria. There were single and similar radioactive major bands in the 10,000-molecular-weight area when the antisera employed were rabbit anti-BCG, rabbit antiH37Rv, and SA-12 but not when the antibodies were directed to a variety of other bacteria. These bands were at the same location as free '25I-BCG-a (Fig. 2) and unlabeled BCG-a (Fig. 1) . Several minor bands not visible in Fig. 2 were occasionally noted in higher-molecular- Fig. 4 .
Inhibition of reaction between SA-12 and '25I-BCG-a by intact BCG. The following experiment was carried out to determine whether intact BCG was capable of inhibiting the reaction between '29I-BCG-a and SA-12. BCG cultures were heat killed, washed, and suspended in sterile water, and dry weights were determined (33) . The preparation used weighed 96.0 mg/ml. Serial dilutions of the cultures were tested for their ability to inhibit the reaction between '25I-BCG-a and SA-12, using the conditions the same as those in the experiments described in Fig. 5 . A 9.6-mg amount of BCG inhibited this reaction by 43.4%, and lower amounts were less effective ( Table 1 Table 2 .
(ii) Amino-terminal sequence determination. Two samples of BCG-a from independent preparations were subjected separately to amino-terminal sequence analysis as described above. Each of these materials produced the sequence shown in Fig. 6 as the only identifiable sequence.
(iii) Lectin chromatography of BCG-a. Lectin chromatography was used to evaluate the presence of certain oligosaccharides in BCG-a. Unlabeled BCG-a (100 rig) was passed over columns consisting of 10 mg of concanavalin-A and 2.5 mg of Lens culinaris lectins, which were insolubilized on beaded agarose (Sigma Chemical Co.). The components possibly bound were eluted with 0.5 M o-methyl-D-mannoside (Sigma Chemical Co.). The bound and unbound materials were dialyzed against PBS, pH 7.0, and tested in an inhibition assay as described above (Fig. 5 ). BCG-a activity was recovered in the unbound effluents from both lectin columns, and no activity was detected in the eluted materials. These experiments do not rule out the possibility that BCG-a is a glycoprotein but suggests that oligosaccharides of the oligomannosyl or fucosylated biantennary types are not present.
Capacity of BCG-a to elicit DCH. The following experiments were carried out to determine whether BCG-a would elicit delayed cutaneous hypersensitivity (DCH) week after the final injection, each animal was tested intradermally with one tuberculin unit of purified protein derivative (Connaught Laboratories Ltd., Willowdale, Canada) and with BCG-a. A third group of eight unimmunized guinea pigs was similarly tested. Reactions were read at 24 h and were considered positive when the diameter of erythema and indurated areas exceeded 10 mm. Results are summarized in Table 3 and indicate that BCG-a is effective as an antigen for eliciting DCH in animals immunized with sonicates of either BCG or H37Rv. DISCUSSION The central step in the purification of the BCG-a antigen described in this report is the use of the SA-12 monoclonal antibody affinity column. The following is a summary of the strategy for producing this antibody. Spleen cells were isolated from mice that had been injected with disrupted BCG. It has been shown that there are differences in antigen expression between intact and disrupted BCG preparations. Mice were therefore immunized with disrupted BCG, which express antigens not necessarily detected on intact BCG (31) . After fusion, a hybridoma was selected that produced antibodies with a high degree of specificity to an antigen of BCG. It was this monoclonal antibody that was used in the affinity chromatography purification of the BCG-a component of BCG. BCG-a, as expected, was bound readily by small quantities of SA-12 (Fig. 3) . It is also noteworthy that BCG-a bound to polyclonal antibodies directed to both BCG and H37Rv. Antibodies to nontuberculous mycobacteria and to nonacid-fast bacteria bound poorly or not at all to BCG-a (Fig. 4) . Immunoprecipitation of antibodies directed to a variety of bacteria with '25I-BCG-a, followed by SDS-PAGE studies confirmed the preferential binding to BCG-a by antibodies directed to BCG and H37Rv. This kind of specificity was also demonstrated by inhibition studies. Binding by SA-12 of '25I-BCG-a was inhibited equally well by extracts of BCG and H37Rv but not as readily by extracts of nontuberculous mycobacteria and not at all by extracts of nonacid-fast bacteria (Fig. 5) . In previous studies, and by way of contrast, the more complex BCG-S antigens were bound by antibodies prepared against many strains of mycobacteria and taxonomically unrelated bacteria (32, 33) . Throughout this study, in which a variety of techniques were employed, significant similarities were demonstrated only between BCG-a and antigens of BCG and of H37Rv.
The reactions between SA-12 and '-5I-BCG-a was readily inhibited by small amounts of unlabeled BCG-a (Fig. 5) , permitting the use of a sensitive competitive radioimmunoassay to detect small amounts of antigen. This system may therefore have a potential capacity for detecting and differentiating mycobacteria under clinical conditions. The data in Table 1 indicate that this reaction can be inhibited by surface antigens on intact, killed BCG. Panels of specific monoclonal antibodies directed to nontuberculous mycobacteria coupled with the use of antigens derived from nontuberculous mycobacteria will extend the patterns of specificity described in this study.
Amino acid analysis and N-terminal sequencing of BCG-a were carried out as a first step in the total structural characterization of the molecule. It will be of interest and value to compare this information with the structures of antigens derived by using monoclonal antibodies directed against other strains of BCG and against strains of other mycobacterial species. Information about the carbohydrate and fatty acid composition of BCG-a is needed to complement the information provided by the protein analyses. Although data presented here suggest that BCG-a does not carry N-linked carbohydrates, the possibility that BCG-a is a glycoprotein has not been ruled out. Monoclonal antibodies have already demonstrated patterns of specificity and reproducibility for the identification of other microorganisms that exceeded those possible with conventionally prepared antibodies (15, 18, 21, 35, 36) . The preliminary studies in this paper hold the attraction that monoclonal antibodies can also be used for the standardization and identification of mycobacterial antigens.
